Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Shares Outstanding (Weighted Average) (2016 - 2025)

MedWellAI (MWAI) has disclosed Shares Outstanding (Weighted Average) for 12 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 554262.67% to $6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, up 554262.67% year-over-year, with the annual reading at $6.2 million for FY2025, 40.19% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $6.2 million at MedWellAI, roughly flat from $6.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $204.3 million in Q4 2021, with the low at $1125.0 in Q4 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $38.3 million, with a median of $4.7 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Weighted Average) crashed 99.97% in 2024, then soared 554262.67% in 2025.
  • Over 5 years, Shares Outstanding (Weighted Average) stood at $204.3 million in 2021, then tumbled by 99.02% to $2.0 million in 2022, then surged by 88.38% to $3.8 million in 2023, then plummeted by 99.97% to $1125.0 in 2024, then skyrocketed by 554262.67% to $6.2 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $6.2 million, $6.2 million, and $6.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.